Inhibition of Adipose Inflammation as a Novel Therapeutic Target for Heart Failure

被引：1
|
作者：
Yoshida, Yohko [1 ]
Shimizu, Ippei [1 ]
Minamino, Tohru [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2012年 / 18卷 / 10期
关键词：
D O I：
10.1016/j.cardfail.2012.08.140
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [31] Novel directions in inflammation as a therapeutic target in atherosclerosis
    Verweij, Simone L.
    van der Valk, Fleur M.
    Stroes, Erik S. G.
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (06) : 580 - 585
  • [32] A novel therapeutic target for attenuating excessive inflammation
    Tsikitis, VL
    Morin, N
    LeBlanc, B
    Harrington, E
    Reichner, J
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (03) : S38 - S39
  • [33] Morbid Obesity as a Therapeutic Target for Heart Failure
    Chonyang L. Albert
    Current Treatment Options in Cardiovascular Medicine, 2019, 21
  • [34] Endothelin in heart failure: A promising therapeutic target?
    Love, MP
    McMurray, JJV
    HEART, 1997, 77 (02) : 93 - 94
  • [35] Mitochondrial function as a therapeutic target in heart failure
    Brown, David A.
    Perry, Justin B.
    Allen, Mitchell E.
    Sabbah, Hani N.
    Stauffer, Brian L.
    Shaikh, Saame Raza
    Cleland, John G. F.
    Colucci, Wilson S.
    Butler, Javed
    Voors, Adriaan A.
    Anker, Stefan D.
    Pitt, Bertram
    Pieske, Burkert
    Filippatos, Gerasimos
    Greene, Stephen J.
    Gheorghiade, Mihai
    NATURE REVIEWS CARDIOLOGY, 2017, 14 (04) : 238 - 250
  • [36] Morbid Obesity as a Therapeutic Target for Heart Failure
    Albert, Chonyang L.
    CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2019, 21 (10)
  • [37] Worsening Heart Failure Challenges as a Therapeutic Target
    Tang, W. H. Wilson
    Grodin, Justin L.
    JACC-HEART FAILURE, 2015, 3 (05) : 404 - 407
  • [38] Phospholamban:: A promising therapeutic target in heart failure?
    Schmidt, AG
    Edes, I
    Kranias, EG
    CARDIOVASCULAR DRUGS AND THERAPY, 2001, 15 (05) : 387 - 396
  • [39] Phospholamban: A Promising Therapeutic Target in Heart Failure?
    Albrecht G. Schmidt
    Istvan Edes
    Evangelia G. Kranias
    Cardiovascular Drugs and Therapy, 2001, 15 : 387 - 396
  • [40] Xanthine oxidase inhibition and heart failure - Novel therapeutic strategy for ventricular dysfunction?
    Hajjar, RJ
    Leopold, JA
    CIRCULATION RESEARCH, 2006, 98 (02) : 169 - 171
12345